NCT03823027View on ClinicalTrials.gov

STAR Study Investigating Performance and Safety of the Medical Device SiPore15™

NACompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

January 28, 2019

Primary Completion Date

October 2, 2019

Study Completion Date

October 2, 2019

Conditions
PreDiabetesPre DiabetesPrediabetic StateType2 DiabetesType2 Diabetes MellitusOverweightObese
Interventions
DEVICE

SiPore15™

SiPore15™ is a taste- and odourless white powder, consisting of precisely engineered micrometre sized synthetic amorphous silicon dioxide. The device is made of pure silicon dioxide, SiO2, which has the CAS Number: 112926-00-8 and EC List number: 601-214-2.

Trial Locations (2)

70100

Pihlajalinna Ite, Satucon OY, Kuopio

752 37

Clinical Trial Consultants, Uppsala

All Listed Sponsors
lead

Sigrid Therapeutics AB

INDUSTRY

NCT03823027 - STAR Study Investigating Performance and Safety of the Medical Device SiPore15™ | Biotech Hunter | Biotech Hunter